The US senior housing sector experienced explosive growth in Q1 2026, fueled by the massive baby boomer generation turning eighty and historically low construction starts. While independent living occupancy reached milestones, assisted living pricing power accelerated sharply. This robust performance and resilient cash flows prompted major global institutional investors to aggressively rotate capital into assets.

The global exoskeleton market is experiencing massive growth, driven by aging workforces, rising injury costs, and technology maturation. Tech giants and national funds are heavily investing, viewing these devices as data gateways. Meanwhile, China is pivoting toward ultra-lightweight, affordable consumer-grade models, reshaping the international landscape through strict cost leadership, rapid patent dominance, and mass-market democratization.

As of 2026, medical aid in dying is legal in 13 states and Washington, D.C. Unlike illegal euthanasia, patients must self-administer the medication. Strict rules require terminal prognoses and verified mental competence. While advocates support it as a victory for patient autonomy, critics, particularly disability rights organizations, raise serious legal and ethical concerns regarding societal vulnerability.